Literature DB >> 32413171

Robust and efficient semi-supervised estimation of average treatment effects with application to electronic health records data.

David Cheng1, Ashwin N Ananthakrishnan2, Tianxi Cai3.   

Abstract

We consider the problem of estimating the average treatment effect (ATE) in a semi-supervised learning setting, where a very small proportion of the entire set of observations are labeled with the true outcome but features predictive of the outcome are available among all observations. This problem arises, for example, when estimating treatment effects in electronic health records (EHR) data because gold-standard outcomes are often not directly observable from the records but are observed for a limited number of patients through small-scale manual chart review. We develop an imputation-based approach for estimating the ATE that is robust to misspecification of the imputation model. This effectively allows information from the predictive features to be safely leveraged to improve efficiency in estimating the ATE. The estimator is additionally doubly-robust in that it is consistent under correct specification of either an initial propensity score model or a baseline outcome model. It is also locally semiparametric efficient under an ideal semi-supervised model where the distribution of the unlabeled data is known. Simulations exhibit the efficiency and robustness of the proposed method compared to existing approaches in finite samples. We illustrate the method by comparing rates of treatment response to two biologic agents for treatment inflammatory bowel disease using EHR data from Partners' Healthcare.
© 2020 The International Biometric Society.

Entities:  

Keywords:  causal inference; double-robustness; missing data; semi-supervised learning; semiparametric efficiency; surrogate outcomes

Mesh:

Year:  2020        PMID: 32413171      PMCID: PMC7758040          DOI: 10.1111/biom.13298

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   1.701


  10 in total

1.  Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study.

Authors:  Jared K Lunceford; Marie Davidian
Journal:  Stat Med       Date:  2004-10-15       Impact factor: 2.373

2.  Doubly robust estimation in missing data and causal inference models.

Authors:  Heejung Bang; James M Robins
Journal:  Biometrics       Date:  2005-12       Impact factor: 2.571

3.  Semiparametric Estimation of Treatment Effect in a Pretest-Posttest Study with Missing Data.

Authors:  Marie Davidian; Anastasios A Tsiatis; Selene Leon
Journal:  Stat Sci       Date:  2005-08       Impact factor: 2.901

4.  Causal inference with missing exposure information: Methods and applications to an obstetric study.

Authors:  Zhiwei Zhang; Wei Liu; Bo Zhang; Li Tang; Jun Zhang
Journal:  Stat Methods Med Res       Date:  2013-12-05       Impact factor: 3.021

5.  Improved double-robust estimation in missing data and causal inference models.

Authors:  Andrea Rotnitzky; Quanhong Lei; Mariela Sued; James M Robins
Journal:  Biometrika       Date:  2012-04-29       Impact factor: 2.445

6.  Doubly robust estimators of causal exposure effects with missing data in the outcome, exposure or a confounder.

Authors:  E J Williamson; A Forbes; R Wolfe
Journal:  Stat Med       Date:  2012-10-22       Impact factor: 2.373

7.  Doubly robust nonparametric inference on the average treatment effect.

Authors:  D Benkeser; M Carone; M J Van Der Laan; P B Gilbert
Journal:  Biometrika       Date:  2017-10-16       Impact factor: 2.445

8.  A Perturbation Method for Inference on Regularized Regression Estimates.

Authors:  Jessica Minnier; Lu Tian; Tianxi Cai
Journal:  J Am Stat Assoc       Date:  2012-01-24       Impact factor: 5.033

9.  Comparative Effectiveness of Infliximab and Adalimumab in Crohn's Disease and Ulcerative Colitis.

Authors:  Ashwin N Ananthakrishnan; Andrew Cagan; Tianxi Cai; Vivian S Gainer; Stanley Y Shaw; Guergana Savova; Susanne Churchill; Elizabeth W Karlson; Isaac Kohane; Katherine P Liao; Shawn N Murphy
Journal:  Inflamm Bowel Dis       Date:  2016-04       Impact factor: 5.325

10.  Estimating average treatment effects with a double-index propensity score.

Authors:  David Cheng; Abhishek Chakrabortty; Ashwin N Ananthakrishnan; Tianxi Cai
Journal:  Biometrics       Date:  2019-12-16       Impact factor: 2.571

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.